{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T22:13:20Z","timestamp":1758406400490},"reference-count":22,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.vaccine.2004.02.014","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T12:37:13Z","timestamp":1078576633000},"page":"3008-3013","source":"Crossref","is-referenced-by-count":8,"title":["PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children"],"prefix":"10.1016","volume":"22","author":[{"given":"C.L","family":"Vermont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.H","family":"van Dijken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"van Alphen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.J.M","family":"van den Dobbelsteen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9\u201310","key":"10.1016\/j.vaccine.2004.02.014_BIB1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(00)00320-0","article-title":"Immunogenicity and safety of monovalent p1.7(h),4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations","volume":"19","author":"de Kleijn","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.02.014_BIB2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/IAI.70.2.584-590.2002","article-title":"Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine","volume":"70","author":"Vermont","year":"2002","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.vaccine.2004.02.014_BIB3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2004.02.014_BIB4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0264-410X(95)98264-B","article-title":"Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine","volume":"13","author":"van der Ley","year":"1995","journal-title":"Vaccine"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2004.02.014_BIB5","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2004.02.014_BIB6","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0264-410X(99)00423-5","article-title":"Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2\u20133 and 7\u20138 years of age","volume":"18","author":"de Kleijn","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2004.02.014_BIB7","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1128\/IAI.71.11.6367-6371.2003","article-title":"Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form","volume":"71","author":"Luijkx","year":"2003","journal-title":"Infect. Immun."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2004.02.014_BIB8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0264-410X(01)00371-1","article-title":"Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine","volume":"20","author":"de Kleijn","year":"2001","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2004.02.014_BIB9","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/S0264-410X(01)00198-0","article-title":"IgG antibody subclass responses determined by immunoblot in infants\u2019 sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine","volume":"19","author":"Martin","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2004.02.014_BIB10","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2004.02.014_BIB11","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/515298","article-title":"Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines","volume":"177","author":"Anttila","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2004.02.014_BIB12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1086\/314901","article-title":"The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination","volume":"180","author":"Goldblatt","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2004.02.014_BIB13","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.vaccine.2004.02.014_BIB14","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.154.8.4195","article-title":"Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates","volume":"154","author":"Lucas","year":"1995","journal-title":"J. Immunol."},{"issue":"19\/20","key":"10.1016\/j.vaccine.2004.02.014_BIB15","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/S0264-410X(02)00151-2","article-title":"Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants","volume":"20","author":"Longworth","year":"2002","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2004.02.014_BIB16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/IAI.58.5.1355-1359.1990","article-title":"Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins","volume":"58","author":"Tommassen","year":"1990","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.vaccine.2004.02.014_BIB17","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"van der Voort","year":"1996","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.vaccine.2004.02.014_BIB18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/IAI.71.4.1650-1655.2003","article-title":"Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine","volume":"71","author":"Vermont","year":"2003","journal-title":"Infect. Immun."},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2004.02.014_BIB19","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0264-410X(98)00458-7","article-title":"Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood","volume":"17","author":"Anttila","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.014_BIB20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/IAI.71.1.275-286.2003","article-title":"Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.vaccine.2004.02.014_BIB21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/MMBR.57.1.34-49.1993","article-title":"Meningococcal lipopolysaccharides: virulence factor and potential vaccine component","volume":"57","author":"Verheul","year":"1993","journal-title":"Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.vaccine.2004.02.014_BIB22","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect. Immun."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:34:29Z","timestamp":1682649269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":22,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0264410X04001616"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}